Financial & competing interests disclosure
This editorial was supported by the Paul K and Anna E Shockey Family Foundation and Bonnie and Kenneth Shockey. IS Zagon and PJ McLaughlin have intellectual property rights and a patent for the use of OGF in gastrointestinal cancers. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.